WO2003018564A1 - Vascular wall-selective acat inhibitor - Google Patents

Vascular wall-selective acat inhibitor Download PDF

Info

Publication number
WO2003018564A1
WO2003018564A1 PCT/JP2002/008343 JP0208343W WO03018564A1 WO 2003018564 A1 WO2003018564 A1 WO 2003018564A1 JP 0208343 W JP0208343 W JP 0208343W WO 03018564 A1 WO03018564 A1 WO 03018564A1
Authority
WO
WIPO (PCT)
Prior art keywords
same
solvates
salts
vascular wall
acat inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2002/008343
Other languages
English (en)
French (fr)
Inventor
Kimiyuki Shibuya
Katsumi Kawamine
Tadaaki Oogiya
Takahiro Kitamura
Toru Miura
Toshiyuki Edano
Yasunobu Yoshinaka
Youichi Yamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Priority to JP2003523227A priority Critical patent/JP4242765B2/ja
Priority to EP02760658A priority patent/EP1431294A4/en
Publication of WO2003018564A1 publication Critical patent/WO2003018564A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PCT/JP2002/008343 2001-08-22 2002-08-19 Vascular wall-selective acat inhibitor Ceased WO2003018564A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2003523227A JP4242765B2 (ja) 2001-08-22 2002-08-19 血管壁選択的なａｃａｔ阻害剤
EP02760658A EP1431294A4 (en) 2001-08-22 2002-08-19 ACAT INHIBITOR WITH SELECTIVITY FOR VESSEL WALLS

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001-251099 2001-08-22
JP2001251099 2001-08-22

Publications (1)

Publication Number Publication Date
WO2003018564A1 true WO2003018564A1 (en) 2003-03-06

Family

ID=19079803

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/008343 Ceased WO2003018564A1 (en) 2001-08-22 2002-08-19 Vascular wall-selective acat inhibitor

Country Status (3)

Country Link
EP (1) EP1431294A4 (ja)
JP (1) JP4242765B2 (ja)
WO (1) WO2003018564A1 (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005070907A1 (en) * 2004-01-26 2005-08-04 Kowa Co., Ltd. Cyclic diamine compound and pharmaceutical containing the same
JP2010538046A (ja) * 2007-09-06 2010-12-09 ガルデルマ・リサーチ・アンド・デヴェロップメント 薬剤使用および美容使用のための、酵素ｓｏａｔ−１の阻害薬としてのｎ−フェニルアセトアミドの誘導体
US20170219001A1 (en) * 2015-08-04 2017-08-03 Aoyama Seisakusho Co., Ltd. Bolt for peeling coating film

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2920774B1 (fr) * 2007-09-06 2009-10-30 Galderma Res & Dev Nouveaux derives de n-phenul acatamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contentant

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0807627A2 (en) * 1996-05-17 1997-11-19 Kowa Company Ltd. Anilide compounds as ACAT inhibitors
EP0987254A1 (en) * 1997-05-26 2000-03-22 Kowa Co., Ltd. Novel cyclic diamine compounds and medicine containing the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0807627A2 (en) * 1996-05-17 1997-11-19 Kowa Company Ltd. Anilide compounds as ACAT inhibitors
EP0987254A1 (en) * 1997-05-26 2000-03-22 Kowa Co., Ltd. Novel cyclic diamine compounds and medicine containing the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1431294A4 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005070907A1 (en) * 2004-01-26 2005-08-04 Kowa Co., Ltd. Cyclic diamine compound and pharmaceutical containing the same
US7163944B2 (en) 2004-01-26 2007-01-16 Kowa Co., Ltd. Cyclic diamine compound and pharmaceutical containing the same
JP2007518681A (ja) * 2004-01-26 2007-07-12 興和株式会社 環状ジアミン化合物及びこれを含有する医薬
JP4852416B2 (ja) * 2004-01-26 2012-01-11 興和株式会社 環状ジアミン化合物及びこれを含有する医薬
JP2010538046A (ja) * 2007-09-06 2010-12-09 ガルデルマ・リサーチ・アンド・デヴェロップメント 薬剤使用および美容使用のための、酵素ｓｏａｔ−１の阻害薬としてのｎ−フェニルアセトアミドの誘導体
US20170219001A1 (en) * 2015-08-04 2017-08-03 Aoyama Seisakusho Co., Ltd. Bolt for peeling coating film

Also Published As

Publication number Publication date
EP1431294A1 (en) 2004-06-23
JPWO2003018564A1 (ja) 2004-12-09
JP4242765B2 (ja) 2009-03-25
EP1431294A4 (en) 2004-09-15

Similar Documents

Publication Publication Date Title
WO2001019776A3 (de) Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften
CA2445145A1 (en) Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes
WO2001019780A3 (de) Neuartige aminodicarbonsäurederivate mit pharmazeutischen eigenschaften
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
PL354004A1 (en) Novel dicarboxylic acid derivatives with pharmaceutical properties
ATE469136T1 (de) Inhibitoren von 11-beta- hydroxysteroiddehydrogenase typ 1
NZ514234A (en) N-cyanomethylamides as protease inhibitors
IL162498A0 (en) (N-sulphonamido) acetamide derivatives and pharmaceutical compositions containing the same
WO2002070510A3 (de) Aminodicarbonsäurederivate mit pharmazeutischen eigenschaften
SE0001899D0 (sv) New compounds
CA2472954A1 (en) Aza-arylpiperazines
DE60142891D1 (de) Azetidinderivate enthaltende pharmazeutische zusammensetzungen, die azetidinderivate und deren herstellung
SE0202462D0 (sv) Novel use
WO2004037789A8 (en) Methylene urea derivatives as raf-kinase inhibitors
MXPA03008215A (es) Inhibidores de integrina alfa v beta 6.
WO2002100886A8 (en) Pyrrolidin-2-one derivatives as inhibitors of factor xa
CA2336412A1 (en) Medicament for treatment of diabetes
NO20052683L (no) Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
GEP20053626B (en) Substituted 8-Arylquinoline Phosphodiesterase-4 Inhibitors, Pharmaceutical Composition Containing Them and Use Thereof
EA200400708A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
WO2003066594A3 (de) 3-alkanoylamino-propionsäure-derivate als inhibitoren des integrins avss6
MY136859A (en) Pyrrolidine derivatives as factor xa inhibitors
WO2005075471A3 (en) Thiazol-compounds as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
HUP0104308A2 (hu) Amidino- és guanidino-azetidinon-származékok, mint triptáz inhibitorok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek
NO20050667L (no) N-substituerte-1H-indol-5-propionsyreforbindelser som PPAR agonister nyttige for behandling av diabetes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003523227

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002760658

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002760658

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002760658

Country of ref document: EP